Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2016 ASCO Annual Meeting /
ASCO 2016: Plenary Session Review

3rd - 7th Jun 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.06.16
Views: 3288
Rating:

Dr Julie Vose - President of ASCO

Dr Vose speaks with ecancertv at ASCO 2016, summarising presentations from the plenary session.

A further interview with Dr Julie Lemieux about the MA.17R trial, extending aromatase inhibitor therapy, will be released soon, or you can hear more data in her press release here.

Details on the presentation from Prof James Perry, in which chemoradiation with temozolomide extended elderly glioblastoma patient survival, can be found in his interview here, or the press announcement here.

Dr Julie Park spoke further about the data presented in this press announcement on double stem cell transplant for children with high-risk neuroblastoma in an upcoming interview.

Prof Antonio Palumbos’ research into daratumumab, and its slowing progression of multiple myeloma, can be seen in his press release here, with more detail from a personal interview coming soon.

ecancer's filming at ASCO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

 

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation